VCEL
Vericel Corporation
Price Chart
Latest Quote
$38.81
+0.35 (+0.91%)
Current Price
| Previous Close | $38.46 |
| Open | $38.46 |
| Day High | $39.19 |
| Day Low | $38.22 |
| Volume | 56,857 |
Stock Information
| Shares Outstanding | 51.07M |
| Total Debt | $95.04M |
| Cash Equivalents | $145.34M |
| Revenue | $292.09M |
| Net Income | $21.46M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.98B |
| P/E Ratio | 90.26 |
| EPS (TTM) | $0.43 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.91B |
| Sales | $292.09M |
| Income | $21.46M |
| Book/sh | $6.98 |
| Cash/sh | $2.85 |
| Employees | 398 |
Financial Ratios
| Quick Ratio | 4.62 |
| Current Ratio | 5.18 |
| Debt/Eq | 26.68 |
Returns & Margins
| ROA | 2.17% |
| ROE | 6.59% |
| Gross Margin | 74.84% |
| Operating Margin | -11.79% |
| Profit Margin | 7.35% |
Ownership
| Insider Ownership | 1.20% |
| Institutional Ownership | 111.21% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 45.55 |
| P/S | 6.79 |
| P/B | 5.56 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $55.43 |
Technical Indicators
| SMA20 | $35.89 |
| SMA50 | $35.13 |
| SMA200 | $35.41 |
| RSI | 71.38 |
| ATR | 1.6475 |
| Shares Float | 50.42M |
| Short Float | 12.81% |
| Short Ratio | 7.80 |
| Volatility | 1.13 |
| Rel Volume | 0.10 |
Performance History
| Week | +3.83% |
| Month | +11.30% |
| Quarter | +20.15% |
| 6 Months | +6.36% |
| YTD | +8.99% |
| Year | -6.68% |
| 3 Years | +13.68% |
| 5 Years | -32.69% |
| 10 Years | +1609.69% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $38.81 | 56,857 |
| 2026-06-16 | $38.46 | 644,400 |
| 2026-06-15 | $38.29 | 476,600 |
| 2026-06-12 | $37.46 | 365,000 |
| 2026-06-11 | $38.57 | 505,200 |
| 2026-06-10 | $37.38 | 617,800 |
| 2026-06-09 | $37.03 | 628,300 |
| 2026-06-08 | $35.77 | 372,000 |
| 2026-06-05 | $36.30 | 558,300 |
| 2026-06-04 | $35.69 | 707,300 |
| 2026-06-03 | $34.74 | 599,600 |
| 2026-06-02 | $34.45 | 940,700 |
| 2026-06-01 | $32.82 | 530,000 |
| 2026-05-29 | $33.33 | 480,600 |
| 2026-05-28 | $34.24 | 397,000 |
| 2026-05-27 | $34.27 | 448,900 |
| 2026-05-26 | $34.97 | 465,500 |
| 2026-05-22 | $34.73 | 383,200 |
| 2026-05-21 | $35.15 | 1,071,900 |
| 2026-05-20 | $35.40 | 634,000 |
| 2026-05-19 | $34.49 | 565,700 |
| 2026-05-18 | $34.87 | 524,300 |
About Vericel Corporation
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
đ° Latest News
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Motley Fool âĸ 2026-05-30T18:59:34Z
US High Growth Tech Stocks To Watch
Simply Wall St. âĸ 2026-05-28T17:38:45Z
MediWound Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-27T14:06:32Z
Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report
Simply Wall St. âĸ 2026-05-09T12:28:19Z
Vericel Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T06:07:54Z
Vericel (VCEL) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T16:31:58Z
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T15:15:09Z
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
Zacks âĸ 2026-05-04T13:55:04Z
Vericel Annual Meeting: Shareholders Elect Seven Directors, Approve Say-on-Pay and PwC Auditor
MarketBeat âĸ 2026-05-01T06:05:32Z
Exploring Three High Growth Tech Stocks In The US Market
Simply Wall St. âĸ 2026-04-29T11:38:25Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $70,660,000 | $65,117,000 | $61,940,000 | $54,577,000 |
| Cost Of Revenue | $70,660,000 | $65,117,000 | $61,940,000 | $54,577,000 |
| Total Revenue | $276,259,000 | $237,224,000 | $197,516,000 | $164,365,000 |
| Operating Revenue | $276,259,000 | $237,224,000 | $197,516,000 | $163,698,000 |
| Expenses | ||||
| Interest Expense | $630,000 | $614,000 | $600,000 | $366,000 |
| Total Expenses | $265,215,000 | $232,705,000 | $203,980,000 | $181,423,000 |
| Other Income Expense | $-44,000 | $195,000 | $64,000 | $95,000 |
| Other Non Operating Income Expenses | $-44,000 | $195,000 | $64,000 | $95,000 |
| Net Non Operating Interest Income Expense | $6,377,000 | $5,796,000 | $4,032,000 | $975,000 |
| Interest Expense Non Operating | $630,000 | $614,000 | $600,000 | $366,000 |
| Operating Expense | $194,555,000 | $167,588,000 | $142,040,000 | $126,846,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net Interest Income | $6,377,000 | $5,796,000 | $4,032,000 | $975,000 |
| Interest Income | $7,007,000 | $6,410,000 | $4,632,000 | $1,341,000 |
| Normalized Income | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net Income From Continuing And Discontinued Operation | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Total Operating Income As Reported | $11,044,000 | $4,519,000 | $-6,464,000 | $-17,058,000 |
| Net Income Common Stockholders | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net Income | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net Income Including Noncontrolling Interests | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net Income Continuous Operations | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Pretax Income | $17,377,000 | $10,510,000 | $-2,368,000 | $-15,988,000 |
| Interest Income Non Operating | $7,007,000 | $6,410,000 | $4,632,000 | $1,341,000 |
| Operating Income | $11,044,000 | $4,519,000 | $-6,464,000 | $-17,058,000 |
| Gross Profit | $205,599,000 | $172,107,000 | $135,576,000 | $109,788,000 |
| Per Share | ||||
| Diluted EPS | $0.32 | $0.20 | $-0.07 | $-0.35 |
| Basic EPS | $0.33 | $0.21 | $-0.07 | $-0.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $29,551,000 | $16,628,000 | $2,864,000 | $-11,641,000 |
| Reconciled Depreciation | $11,544,000 | $5,504,000 | $4,632,000 | $3,981,000 |
| EBITDA (Bullshit earnings) | $29,551,000 | $16,628,000 | $2,864,000 | $-11,641,000 |
| EBIT | $18,007,000 | $11,124,000 | $-1,768,000 | $-15,622,000 |
| Diluted Average Shares | $52,151,000 | $51,679,000 | $47,590,000 | $47,130,000 |
| Basic Average Shares | $50,340,000 | $48,848,000 | $47,590,000 | $47,130,000 |
| Diluted NI Availto Com Stockholders | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Tax Provision | $859,000 | $148,000 | $814,000 | $721,000 |
| Research And Development | $27,563,000 | $24,797,000 | $21,042,000 | $19,943,000 |
| Selling General And Administration | $166,992,000 | $142,791,000 | $120,998,000 | $106,903,000 |
Fetched: 2026-06-07
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $349,015,000 | $285,717,000 | $219,077,000 | $184,772,000 |
| Total Assets | $487,969,000 | $432,722,000 | $353,657,000 | $273,003,000 |
| Total Non Current Assets | $240,532,000 | $219,945,000 | $148,026,000 | $86,137,000 |
| Other Non Current Assets | $341,000 | $556,000 | $771,000 | $1,303,000 |
| Investmentin Financial Assets | $61,395,000 | $39,880,000 | $25,283,000 | $19,962,000 |
| Goodwill And Other Intangible Assets | $5,625,000 | $6,250,000 | $6,875,000 | $7,500,000 |
| Other Intangible Assets | $5,625,000 | $6,250,000 | $6,875,000 | - |
| Current Assets | $247,437,000 | $212,777,000 | $205,631,000 | $186,866,000 |
| Other Current Assets | $7,744,000 | $7,287,000 | $6,853,000 | $4,803,000 |
| Restricted Cash | $0 | $10,529,000 | $17,778,000 | $0 |
| Inventory | $17,560,000 | $17,373,000 | $13,087,000 | $15,986,000 |
| Receivables | $84,634,000 | $61,375,000 | $58,356,000 | $46,539,000 |
| Accounts Receivable | $84,634,000 | $61,375,000 | $58,356,000 | $46,539,000 |
| Allowance For Doubtful Accounts Receivable | $-13,000 | $-10,000 | $-43,000 | $-47,000 |
| Gross Accounts Receivable | $84,647,000 | $61,385,000 | $58,399,000 | $46,586,000 |
| Cash Cash Equivalents And Short Term Investments | $137,499,000 | $116,213,000 | $109,557,000 | $119,538,000 |
| Cash And Cash Equivalents | $100,092,000 | $74,520,000 | $69,088,000 | $51,067,000 |
| Debt | ||||
| Total Debt | $96,369,000 | $98,966,000 | $88,043,000 | $47,570,000 |
| Long Term Debt And Capital Lease Obligation | $82,284,000 | $89,593,000 | $81,856,000 | $43,268,000 |
| Current Debt And Capital Lease Obligation | $14,085,000 | $9,373,000 | $6,187,000 | $4,302,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $133,329,000 | $140,755,000 | $127,705,000 | $80,731,000 |
| Total Non Current Liabilities Net Minority Interest | $84,180,000 | $90,469,000 | $81,956,000 | $43,268,000 |
| Other Non Current Liabilities | $1,896,000 | $876,000 | $100,000 | - |
| Current Liabilities | $49,149,000 | $50,286,000 | $45,749,000 | $37,463,000 |
| Payables And Accrued Expenses | $20,802,000 | $27,331,000 | $26,302,000 | $22,887,000 |
| Payables | $15,828,000 | $23,848,000 | $22,347,000 | $16,930,000 |
| Accounts Payable | $15,828,000 | $23,848,000 | $22,347,000 | $16,930,000 |
| Other Current Liabilities | - | $116,000 | - | $41,000 |
| Equity | ||||
| Common Stock Equity | $354,640,000 | $291,967,000 | $225,952,000 | $192,272,000 |
| Total Equity Gross Minority Interest | $354,640,000 | $291,967,000 | $225,952,000 | $192,272,000 |
| Stockholders Equity | $354,640,000 | $291,967,000 | $225,952,000 | $192,272,000 |
| Gains Losses Not Affecting Retained Earnings | $275,000 | $4,000 | $-100,000 | $-978,000 |
| Other Equity Adjustments | $275,000 | $4,000 | $-100,000 | $-978,000 |
| Retained Earnings | $-376,297,000 | $-392,815,000 | $-403,177,000 | $-399,995,000 |
| Other | ||||
| Ordinary Shares Number | $50,620,000 | $49,628,000 | $47,829,000 | $47,253,000 |
| Share Issued | $50,620,000 | $49,628,000 | $47,829,000 | $47,253,000 |
| Tangible Book Value | $349,015,000 | $285,717,000 | $219,077,000 | $184,772,000 |
| Invested Capital | $354,640,000 | $291,967,000 | $225,952,000 | $192,272,000 |
| Working Capital | $198,288,000 | $162,491,000 | $159,882,000 | $149,403,000 |
| Capital Lease Obligations | $96,369,000 | $98,966,000 | $88,043,000 | $47,570,000 |
| Total Capitalization | $354,640,000 | $291,967,000 | $225,952,000 | $192,272,000 |
| Capital Stock | $730,662,000 | $684,778,000 | $629,229,000 | $593,245,000 |
| Common Stock | $730,662,000 | $684,778,000 | $629,229,000 | $593,245,000 |
| Long Term Capital Lease Obligation | $82,284,000 | $89,593,000 | $81,856,000 | $43,268,000 |
| Current Capital Lease Obligation | $14,085,000 | $9,373,000 | $6,187,000 | $4,302,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $14,262,000 | $13,582,000 | $13,260,000 | $10,233,000 |
| Current Accrued Expenses | $4,974,000 | $3,483,000 | $3,955,000 | $5,957,000 |
| Investments And Advances | $61,395,000 | $39,880,000 | $25,283,000 | $19,962,000 |
| Available For Sale Securities | $61,395,000 | $39,880,000 | $25,283,000 | $19,962,000 |
| Net PPE | $173,171,000 | $173,259,000 | $115,097,000 | $57,372,000 |
| Accumulated Depreciation | $-31,550,000 | $-26,899,000 | $-22,206,000 | $-18,302,000 |
| Gross PPE | $204,721,000 | $200,158,000 | $137,303,000 | $75,674,000 |
| Leases | $76,421,000 | $77,990,000 | $14,901,000 | $13,689,000 |
| Construction In Progress | $24,651,000 | $22,482,000 | $32,531,000 | $5,438,000 |
| Other Properties | $64,774,000 | $70,098,000 | $73,462,000 | $41,572,000 |
| Machinery Furniture Equipment | $38,875,000 | $29,588,000 | $16,409,000 | $14,975,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $3,023,000 | $2,975,000 | $529,000 | $53,000 |
| Work In Process | $1,584,000 | $1,571,000 | $1,210,000 | $832,000 |
| Raw Materials | $12,953,000 | $12,827,000 | $11,348,000 | $15,101,000 |
| Other Short Term Investments | $37,407,000 | $41,693,000 | $40,469,000 | $68,471,000 |
Fetched: 2026-06-07
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $24,748,000 | $-5,811,000 | $7,798,000 | $10,091,000 |
| Operating Activities | ||||
| Operating Cash Flow | $51,910,000 | $58,163,000 | $35,311,000 | $17,687,000 |
| Cash Flow From Continuing Operating Activities | $51,910,000 | $58,163,000 | $35,311,000 | $17,687,000 |
| Investing Activities | ||||
| Capital Expenditure | $-27,162,000 | $-63,974,000 | $-27,513,000 | $-7,596,000 |
| Investing Cash Flow | $-43,937,000 | $-79,034,000 | $-3,130,000 | $-36,206,000 |
| Cash Flow From Continuing Investing Activities | $-43,937,000 | $-79,034,000 | $-3,130,000 | $-36,206,000 |
| Capital Expenditure Reported | $-27,162,000 | $-63,974,000 | $-20,013,000 | $-7,596,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,934,000 | $24,516,000 | $6,000,000 | $3,652,000 |
| Financing Cash Flow | $7,070,000 | $19,054,000 | $3,618,000 | $1,045,000 |
| Cash Flow From Continuing Financing Activities | $7,070,000 | $19,054,000 | $3,618,000 | $1,045,000 |
| Net Other Financing Charges | $-6,864,000 | $-5,462,000 | $-2,382,000 | $-2,607,000 |
| Net Common Stock Issuance | $13,934,000 | $24,516,000 | $6,000,000 | $3,652,000 |
| Common Stock Issuance | $13,934,000 | $24,516,000 | $6,000,000 | $3,652,000 |
| Other | ||||
| Interest Paid Supplemental Data | $489,000 | $399,000 | $383,000 | $109,000 |
| Income Tax Paid Supplemental Data | $580,000 | $628,000 | $1,166,000 | $0 |
| End Cash Position | $100,092,000 | $85,049,000 | $86,866,000 | $51,067,000 |
| Beginning Cash Position | $85,049,000 | $86,866,000 | $51,067,000 | $68,541,000 |
| Changes In Cash | $15,043,000 | $-1,817,000 | $35,799,000 | $-17,474,000 |
| Net Investment Purchase And Sale | $-16,775,000 | $-15,060,000 | $24,383,000 | $-28,610,000 |
| Sale Of Investment | $55,596,000 | $53,151,000 | $79,608,000 | $40,944,000 |
| Purchase Of Investment | $-72,371,000 | $-68,211,000 | $-55,225,000 | $-69,554,000 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-7,500,000 | $0 |
| Purchase Of Intangibles | $0 | $0 | $-7,500,000 | $0 |
| Change In Working Capital | $-21,357,000 | $-450,000 | $-3,964,000 | $-11,209,000 |
| Change In Other Working Capital | $1,067,000 | $205,000 | $100,000 | - |
| Change In Other Current Liabilities | $-2,623,000 | $7,520,000 | $2,513,000 | $-2,527,000 |
| Change In Other Current Assets | $-457,000 | $-434,000 | $-1,733,000 | $-557,000 |
| Change In Payables And Accrued Expense | $5,145,000 | $-436,000 | $4,074,000 | $3,582,000 |
| Change In Accrued Expense | $2,171,000 | $-149,000 | $1,025,000 | $2,145,000 |
| Change In Payable | $2,974,000 | $-287,000 | $3,049,000 | $1,437,000 |
| Change In Account Payable | $2,974,000 | $-287,000 | $3,049,000 | $1,437,000 |
| Change In Inventory | $-1,230,000 | $-4,286,000 | $2,899,000 | $-2,605,000 |
| Change In Receivables | $-23,259,000 | $-3,019,000 | $-11,817,000 | $-9,102,000 |
| Changes In Account Receivables | $-23,259,000 | $-3,019,000 | $-11,817,000 | $-9,102,000 |
| Other Non Cash Items | $5,578,000 | $6,909,000 | $6,324,000 | $4,334,000 |
| Stock Based Compensation | $38,767,000 | $36,495,000 | $32,325,000 | $37,183,000 |
| Provisionand Write Offof Assets | $1,043,000 | $0 | $0 | - |
| Amortization Of Securities | $-183,000 | $-657,000 | $-824,000 | $107,000 |
| Depreciation Amortization Depletion | $11,544,000 | $5,504,000 | $4,632,000 | $3,981,000 |
| Depreciation And Amortization | $11,544,000 | $5,504,000 | $4,632,000 | $3,981,000 |
| Net Income From Continuing Operations | $16,518,000 | $10,362,000 | $-3,182,000 | $-16,709,000 |
| Net PPE Purchase And Sale | - | - | - | - |
| Purchase Of PPE | - | - | - | - |
Fetched: 2026-06-07